Nordisk

“So Nordisk, rather than building up production facilities around the world, what they decide to do is license it back to basically any interested pharma company. So like Eli Lilly back in the States, other companies in Continental Europe. It's the new, widely …”

“So they go to market, Novo goes to market with their Novo insulin as insulin at half price because it's so much more efficient.”

“So for the entire decade of the 19 seventies, Nordisk's sales grow at 30% compounded annually, which is amazing.”

“Novo's annual global insulin sales, this is Novo, they're still much larger. They're about a hundred million dollars annually. And Nordisk's are about thirty million annually. That makes them the number two and number four producers in the world by market shar…”

“What Nordisk was originally producing, were insulin tablets Solid insulin tablets. Now, until recent times, you can't take insulin in tablet form. It doesn't get absorbed by the gut. You have to inject it. So what patients had to do was take these solid tablet…”

“And for the next 65 years, these two companies would compete In blood sport, head to head, hated each other, absolutely hated each other until they finally merged in 1989.”

“It actually ends up going to the Danish Supreme Court, where Hagedorn represents Nordisk himself. You know, in the lower courts, they had lawyers, and I think they lost the case in the lower courts, and Hagedorn's like, screw this. I'm gonna be my own lawyer. …”